A phase II study of resection followed capecitabine + oxaliplatin for liver metastasis of colorectal cancer. [REX study]

ABSTRACT: Interventions: Surgical hepatectomy followed by chemotherapy (XELOX)8cycles. (L-OHP 130 mg/m2 day1 , Capecitabine 2,000mg/m2/day day1-14) Primary outcome(s): 3-year Disease-Free Survival Study Design: Single arm Non-randomized

DISEASE(S): Liver Metastases Of Colorectal Cancer

PROVIDER: 2628675 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR